Kedbumin Human Albumin 25%

What is Kedbumin Human Albumin 25%

Kedbumin is a sterile, single dose solution containing 0.25 g per mL human albumin as 12.5 g albumin per 50 mL single dose vial.

Indications

  • Hypovolemic shock – For restoration and maintenance of circulating blood volume where volume deficiency is demonstrated and colloid use is appropriate.
  • Hypoalbuminemia – Kedbumin is indicated for severe albumin deficiency caused by illness or active bleeding
  • Prevention of central volume depletion after paracentesis due to cirrhotic ascites – Kedbumin is indicated for maintenance of cardiovascular function following the removal of large volumes of ascitic fluid due to cirrhosis
  • Ovarian Hyperstimulation Syndrome (OHSS) – as a plasma expander in the fluid management in of severe forms of ovarian hyperstimulation syndrome (OHSS)
  • Adult Respiratory Distress Syndrome (ARDS) – is indicated in conjunction with diuretics to correct fluid volume overload associated with ARDS
  • Burns – is indicated after > 24 hours post burn in patients experiencing severe albumin depletion in order to favor edema reabsorption
  • Hemodialysis patients undergoing long term dialysis – is indicated in patients undergoing long term dialysis or for those patients who are fluid-overloaded and cannot tolerate substantial volumes of salt solution for therapy of shock or hypotension
  • Patients who cannot tolerate substantial volumes of salt solution
  • Priming solution for cardiopulmonary bypass – is indicated in cardiopulmonary bypass procedures as part of the priming fluids

Side Effects

  1. flushing
  2. urticaria
  3. fever
  4. chills
  5. nausea
  6. vomiting
  7. tachycardia
  8. hypotension
You cannot copy content of this page